Cognition Therapeutics, Inc.

NASDAQ:CGTX

Biotechnology

Healthcare
$0.60 -0.70%

-$0.01 today

Market cap
$57.12M
Beta
1.75
P/E (TTM)
-6.4
EPS (TTM)
-$0.22
52W Low $0.25High $3.83

Volume 0.33M

Average 1.23M

Price history

Cognition Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-54.84%

Period high

$1.80

Period low

$0.59

Latest

$0.60

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KOct 22, 2026Oct 22, 2026
10-QAug 7, 2026Aug 7, 2026
8-KAug 6, 2026Aug 6, 2026
8-KJun 24, 2026Jun 24, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
8-KJun 18, 2026Jun 18, 2026
8-KJun 4, 2026Jun 4, 2026
8-KMay 21, 2026May 21, 2026
10-QMay 8, 2026May 8, 2026

Competitors

Who does Cognition Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CGTX's filings, answered from its disclosures.

What is the latest CGTX filing?

The latest filing shown is 10-Q dated Nov 5, 2026.

How many recent filings does CGTX have?

Intrinsic Alpha currently shows 20 recent filings for CGTX.